Journal
ACTA BIOMATERIALIA
Volume 144, Issue -, Pages 132-141Publisher
ELSEVIER SCI LTD
DOI: 10.1016/j.actbio.2022.03.023
Keywords
Metal-organic framework; Photothermal therapy; Immunogenic cell death; Immune checkpoint blockade; Combination therapy
Funding
- National Natural Science Foundation of China [51925305, 51873208, 52073278]
- Jilin Province Science and Technology Development Program [2020080210GH]
- Jilin Province Finance Development Program [JLSWSRCZX20200016]
- Health Commission of Jilin Province [2021JC036]
Ask authors/readers for more resources
Due to the molecular heterogeneity of tumors, clinical outcomes of tumor treatment are unsatisfactory, necessitating novel strategies. Combination therapy enhances tumor treatment by stimulating multiple pathways, reducing systemic toxicity, and regulating tumor immune microenvironments. In this study, multifunctional nanoparticles were synthesized and used for imaging-guided therapy, combining chemotherapy and photothermal therapy to efficiently kill tumor cells and induce immunogenic cell death and T cell activation, resulting in systemic antitumor immunity.
Because of molecular heterogeneity in tumors, clinical outcomes of tumor treatment are not very satisfactory, and novel strategies are therefore needed to address this challenge. Combination therapy could efficiently enhance tumor treatment by stimulating multiple pathways, reducing the systemic toxicity of monotherapy, and regulating the tumor immune microenvironments. Herein, metal-organic framework MIL-100 (Fe) nanoparticles (NPs) were synthesized by a microwave-assisted method, and oxaliplatin (OXA) and indocyanine green (ICG) were then loaded into hyaluronic acid (HA)-modified MIL-100 NPs to obtain multifunctional nanoparticles (OIMH NPs). The OIMH NPs exhibited sensitive photoacoustic imaging (PAI) for imaging-guided therapy and showed a good synergistic effect by combining chemotherapy with photothermal therapy (PIT) to kill tumor cells. Immunogenic cell death (ICD) and activation of T cells induced by the chemo-photothermal therapy could sensitize for immune checkpoint blockade (aPD-L1) response, thus eliciting systemic antitumor immunity. Finally, tumor inhibition was observed, which could be attributed to the combination of chemotherapy, PIT, and aPD-L1. On the basis of the study findings, an innovative imaging-mediated combined therapeutic strategy involving multifunctional NPs was proposed, which might potentially offer a new clinical treatment for colorectal cancer. Statement of significance The metal-organic framework-mediated chemo-photothermal therapy guided by photoacoustic imaging (PAI) is an accurate and effective approach for tumor inhibition, which can synergistically achieve immunogenic cell death and lead to an increasing infiltration of immune cells in the tumor microenvironment, thereby enhancing the sensitivity for immune checkpoint blockade (aPD-L1) therapy. This type of therapy can not only reduce the systemic toxicity caused by traditional treatment methods, but it can also solve the issue of low response of immune checkpoint blockade in colorectal cancer (CRC). Our study provides experimental evidence for using the combination of immunotherapy and chemo-photothermal therapy against CRC. (C) 2022 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available